Transplantation Pathology

  • Oscar W. Cummings


The aim of this chapter is to provide a practical, concise review of transplantation pathology. A brief review of transplantation immunology is given to put some of the aspects of clinical transplantation care into perspective. Complications of transplantation common to all organs are also addressed. All the criteria for diagnosis are highlighted in boxed tables for easy reference with illustrations for most. The criteria for cardiac rejection have been recently revised. A table is provided to correlate the old grading system with the new one. Grading systems for liver, lung, small bowel, and graft vs. host disease (GVHD) are largely unchanged since the previous edition. New grading systems for pancreas and skin-containing allografts (i.e., limb and face) are also included.


Chronic Rejection Obliterative Bronchiolitis Bronchiolitis Obliterans Syndrome Acute Cellular Rejection Posttransplant Lymphoproliferative Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading


  1. Abu-Elmagd KM, Zak M, Stamos JM, et al. De novo malignancies after intestinal and multivisceral transplantation. Transplantation 2004;77:1719–1725.PubMedGoogle Scholar
  2. Boros P, Bromberg JS . De novo autoimmunity after organ transplantation: targets and possible pathways. Hum Immunol 2008;69:383–388.PubMedGoogle Scholar
  3. Bromberg JS, Halloran PF . Nine things you might not say or hear in transplantation. Am J Transplant 2009;9:11–13.PubMedGoogle Scholar
  4. Buckley RH . 27. Transplantation immunology: organ and bone marrow. J Allergy Clin Immunol 2003;111:S733–S744.PubMedGoogle Scholar
  5. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R, Lascurain R . Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 2009;6:15–25.PubMedGoogle Scholar
  6. Dijke IE, Weimar W, Baan CC . Regulatory T cells after organ transplantation: where does their action take place? Hum Immunol 2008;69:389–398.PubMedGoogle Scholar
  7. Dragun D. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Transplantation 2008;86:1019–1025.PubMedGoogle Scholar
  8. Everly MJ, Bloom RD, Tsai DE, Trofe J. Posttransplant lymphoproliferative disorder. Ann Pharmacother 2007;41:1850–1858.PubMedGoogle Scholar
  9. Fernandez MC, Bes D, De Davila M , et al. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome. Pediatr Transplant 2009;13:307–310.PubMedGoogle Scholar
  10. Fildes JE, Yonan N, Leonard CT . Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance. Transpl Immunol 2008;19:1–11.PubMedGoogle Scholar
  11. Gokmen MR, Lombardi G, Lechler RI . The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol 2008;20:568–574.PubMedGoogle Scholar
  12. Hawksworth JS, Leeser D, Jindal RM, Falta E, Tadaki D, Elster EA . New directions for induction immunosuppression strategy in solid organ transplantation. Am J Surg 2009;197:515–524.PubMedGoogle Scholar
  13. Heeger PS . T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 2003;3:525–533.PubMedGoogle Scholar
  14. Kaposztas Z, Podder H, Mauiyyedi S , et al. Impact of rituximab therapy for treatment of acute humoral rejection. Clin Transplant 2009;23:63–73.PubMedGoogle Scholar
  15. Kirk AD . Clinical tolerance 2008. Transplantation 2009;87:953–955.PubMedGoogle Scholar
  16. Land W . Postischemic reperfusion injury to allografts – a case for ‘innate immunity’? Eur Surg Res 2002;34:160–169.PubMedGoogle Scholar
  17. Lutz J, Heemann U . Tumours after kidney transplantation. Curr Opin Urol 2003;13:105–109.PubMedGoogle Scholar
  18. Markin RS, Stratta RJ, Woods GL . Infection after liver transplantation. Am J Surg Pathol 1990;14:67–78.Google Scholar
  19. Michaels PJ, Fishbein MC, Colvin RB . Humoral rejection of human organ transplants. Springer Semin Immunopathol 2003;25:119–140.PubMedGoogle Scholar
  20. Pietra BA . Transplantation immunology 2003: simplified approach. Pediatr Clin North Am 2003;50:1233–1259.PubMedGoogle Scholar
  21. Roland ME, Stock PG . Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003;75:425–429.PubMedGoogle Scholar
  22. Schmook T, Nindl I, Ulrich C, Meyer T, Sterry W, Stockfleth E . Viral warts in organ transplant recipients: new aspects in therapy. Br J Dermatol 2003;149 Suppl 66:20–24.PubMedGoogle Scholar
  23. Sumitran-Holgersson S . Relevance of MICA and other non-HLA antibodies in clinical transplantation. Curr Opin Immunol 2008;20:607–613.PubMedGoogle Scholar
  24. Swerdlow SH, Webber SA, Chadburn A, Ferry JA . Posttransplant lymphoproliferative disorders. In: Swerdlow SH, Cancer. IAfRo, Organization. WH, eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Geneva, Switzerland: WHO Press; 2008:343–349.Google Scholar
  25. Terasaki PI . Humoral theory of transplantation. Am J Transplant 2003;3:665–673.PubMedGoogle Scholar
  26. Tsao L, Hsi ED . The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Arch Pathol Lab Med 2007;131:1209–1218.PubMedGoogle Scholar


  1. Chadban S . Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 2001;12:394–402.PubMedGoogle Scholar
  2. Colvin RB . Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007;18:1046–1056.PubMedGoogle Scholar
  3. Gupta G, Shapiro R, Girnita A , et al. Neutrophilic tubulitis as a marker for urinary tract infection in renal allograft biopsies with C4d deposition. Transplantation 2009;87:1013–1018.PubMedGoogle Scholar
  4. Kaplan B, Srinivas TR, Meier-Kriesche HU . Factors associated with long-term renal allograft survival. Ther Drug Monit 2002;24:36–39.PubMedGoogle Scholar
  5. Mengel M, Sis B, Halloran PF . SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007;7:2221–2226.PubMedGoogle Scholar
  6. Montgomery RA, Locke JE, King KE , et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009;87:1246–1255.PubMedGoogle Scholar
  7. Nickeleit V, Andreoni K . The classification and treatment of antibody-mediated renal allograft injury: where do we stand? Kidney Int 2007;71:7–11.PubMedGoogle Scholar
  8. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003;3:708–714.PubMedGoogle Scholar
  9. Racusen LC, Solez K, Colvin RB , et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713–723.PubMedGoogle Scholar
  10. Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K . The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction. Nephrol Dial Transplant 2008;23:1735–1741.PubMedGoogle Scholar
  11. Solez K, Colvin RB, Racusen LC, et al. Banff ’05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007;7:518–526.PubMedGoogle Scholar
  12. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8:753–760.PubMedGoogle Scholar
  13. Truong LD, Barrios R, Adrogue HE, Gaber LW . Acute antibody-mediated rejection of renal transplant: pathogenetic and diagnostic considerations. Arch Pathol Lab Med 2007;131:1200–1208.PubMedGoogle Scholar
  14. White LH, Casian A, Hilton R, et al. BK virus nephropathy in renal transplant patients in London. Transplantation 2008;85:1008–1015.PubMedGoogle Scholar


  1. Almuti K, Haythe J, Dwyer E, et al. The changing pattern of humoral rejection in cardiac transplant recipients. Transplantation 2007;84:498–503.PubMedGoogle Scholar
  2. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9:587–593.PubMedGoogle Scholar
  3. Bonnaud EN, Lewis NP, Masek MA, Billingham ME. Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant 1995;14:163–171.PubMedGoogle Scholar
  4. Jonigk D, Lehmann U, Stuht S , et al. Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allografts. Transplantation 2007;84:1335–1342.PubMedGoogle Scholar
  5. Joshi A, Masek MA, Brown BW, Jr., Weiss LM, Billingham ME. “Quilty” revisited: a 10-year perspective. Hum Pathol 1995;26:547–557.PubMedGoogle Scholar
  6. Luthringer DJ, Yamashita JT, Czer LS, Trento A, Fishbein MC. Nature and significance of epicardial lymphoid infiltrates in cardiac allografts. J Heart Lung Transplant1995;14:537–543.PubMedGoogle Scholar
  7. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant2006;25:153–159.PubMedGoogle Scholar
  8. Scott RL, Ratliff NB, Starling RC, Young JB. Recurrence of giant cell myocarditis in cardiac allograft. J Heart Lung Transplant 2001;20:375–380.PubMedGoogle Scholar
  9. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710–1720.PubMedGoogle Scholar
  10. Tan CD, Baldwin WM 3rd, Rodriguez ER. Update on cardiac transplantation pathology. Arch Pathol Lab Med 2007;131:1169–1191.PubMedGoogle Scholar
  11. Uber WE, Self SE, Van Bakel AB, Pereira NL. Acute antibody-mediated rejection following heart transplantation. Am J Transplant 2007;7:2064–2074.PubMedGoogle Scholar


  1. Belperio JA, Weigt SS, Fishbein MC, Lynch JP 3rd. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 2009; 6:108–121.PubMedGoogle Scholar
  2. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007;117:3498–3506.PubMedGoogle Scholar
  3. Cagle PT, Brown RW, Frost A, Kellar C, Yousem SA. Diagnosis of chronic lung transplant rejection by transbronchial biopsy. Mod Pathol 1995;8:137–142.PubMedGoogle Scholar
  4. Chakinala MM, Trulock EP. Acute allograft rejection after lung transplantation: diagnosis and therapy. Chest Surg Clin N Am 2003;13:525–542.PubMedGoogle Scholar
  5. Hasegawa T, Iacono AT, Yousem SA. The anatomic distribution of acute cellular rejection in the allograft lung. Ann Thorac Surg 2000;69:1529–1531.PubMedGoogle Scholar
  6. Morrell MR, Patterson GA, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant 2009;28:96–100.PubMedGoogle Scholar
  7. Ng CY, Madsen JC, Rosengard BR , Allan JS. Immunosuppression for lung transplantation. Front Biosci 2009;14:1627–1641.PubMedGoogle Scholar
  8. Rosendale B, Yousem SA. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. Arch Pathol Lab Med 1995;119:418–423.PubMedGoogle Scholar
  9. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002;21:271–281.PubMedGoogle Scholar
  10. Shilling RA, Wilkes DS. Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond. Am J Transplant 2009;9:1714–1718.PubMedGoogle Scholar
  11. Snell GI, Boehler A, Glanville AR, et al. Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation. J Heart Lung Transplant 2007;26:423–430.PubMedGoogle Scholar
  12. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26:1229–1242.PubMedGoogle Scholar


  1. Adam R, Hoti E. Liver transplantation: the current situation. Semin Liver Dis 2009;29:3–18.PubMedGoogle Scholar
  2. Bellamy CO, Herriot MM, Harrison DJ, Bathgate AJ. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology 2007;50:739–749.PubMedGoogle Scholar
  3. Demetris AJ, Adeyi O, Bellamy CO, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006;44:489–501.PubMedGoogle Scholar
  4. Demetris AJ, Eghtesad B, Marcos A, et al. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004;28:658–669.PubMedGoogle Scholar
  5. Demetris AJ, Lunz JG 3rd, Randhawa P, Wu T, Nalesnik M, Thomson AW. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective. Transpl Int 2009;22:120–141.PubMedGoogle Scholar
  6. Demetris AJ, Sebagh M. Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis? Liver Transpl 2008;14:750–755.PubMedGoogle Scholar
  7. Demetrius Aipico AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997;25:658–663.Google Scholar
  8. Drachenberg CB, Abruzzo LV, Klassen DK, et al. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection. Hum Pathol 1998;29:569–577.PubMedGoogle Scholar
  9. Drachenberg CB, Odorico J, Demetris AJ, et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant 2008;8:1237–1249.PubMedGoogle Scholar
  10. Gangemi A, Salehi P, Hatipoglu B, et al. Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant 2008;8:1250–1261.PubMedGoogle Scholar
  11. Geissler EK, Schlitt HJ. Immunosuppression for liver transplantation. Gut 2009;58:452–463.PubMedGoogle Scholar
  12. Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006;12:440–447.PubMedGoogle Scholar
  13. Hubscher SG . Transplantation pathology. Semin Liver Dis 2009;29:74–90.PubMedGoogle Scholar
  14. Inverardi L, Kenyon NS, Ricordi C. Islet transplantation: immunological perspectives. Curr Opin Immunol 2003;15:507–511.PubMedGoogle Scholar
  15. Kashyap R, Jain A, Reyes J, et al. Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years followup. Transplant Proc 2001;33:1486–1487.PubMedGoogle Scholar
  16. Kerkar N, Hadzic N, Davies ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409–413.PubMedGoogle Scholar
  17. Krasinskas AM, Demetris AJ, Poterucha JJ, Abraham SC . The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Liver Transpl 2008;14:625–632.PubMedGoogle Scholar
  18. Larson-Wadd K, Belani KG. Pancreas and islet cell transplantation. Anesthesiol Clin North America 2004;22:663–674.PubMedGoogle Scholar
  19. Melcher ML, Olson JL, Baxter-Lowe LA, Stock PG, Posselt AM. Antibody-mediated rejection of a pancreas allograft. Am J Transplant 2006;6:423–428.PubMedGoogle Scholar
  20. Miyagawa-Hayashino A, Haga H, Egawa H, et al. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation 2004;78:128–135.PubMedGoogle Scholar
  21. Netto GJ, Watkins DL, Williams JW, et al. Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the “hepatitis C 3” multi-institutional trial experience. Arch Pathol Lab Med 2006;130:1157–1162.PubMedGoogle Scholar


  1. Randhawa P, Blakolmer K, Kashyap R, et al. Allograft liver biopsy in patients with Epstein-Barr virus-associated posttransplant lymphoproliferative disease. Am J Surg Pathol 2001;25:324–330.PubMedGoogle Scholar
  2. Sakashita H, Haga H, Ashihara E, et al. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007;20:676–684.PubMedGoogle Scholar
  3. Shyr YM . Pancreas transplantation. J Chin Med Assoc 2009;72:4–9.PubMedGoogle Scholar
  4. Troxell ML, Higgins JP, Kambham N . Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med 2006;130:1489–1496.PubMedGoogle Scholar
  5. White SA, Shaw JA, Sutherland DE . Pancreas transplantation. Lancet 2009;373:1808–1817.PubMedGoogle Scholar
  6. Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28:638–645.PubMedGoogle Scholar

Small Bowel

  1. Adeyi OA, Randhawa PA, Nalesnik MA, et al. Posttransplant adenoviral enteropathy in patients with small bowel transplantation. Arch Pathol Lab Med 2008;132:703–705.PubMedGoogle Scholar
  2. de Serre NP, Canioni D, Lacaille F, et al. Evaluation of c4d deposition and circulating antibody in small bowel transplantation. Am J Transplant 2008;8:1290–1296.PubMedGoogle Scholar
  3. Eisengart LJ, Chou PM, Iyer K, Cohran V, Rajaram V. Rotavirus infection in small bowel transplant: a histologic comparison with acute cellular rejection. Pediatr Dev Pathol 2009;12:85–88.PubMedGoogle Scholar
  4. Garcia M, Delacruz V, Ortiz R, et al. Acute cellular rejection grading scheme for human gastric allografts. Human Pathol 2001;35:343–349.Google Scholar
  5. Giovanelli M, Gupte GL, Sharif K, Mayer DA, Mirza DF. Chronic rejection after combined liver and small bowel transplantation in a child with chronic intestinal pseudo-obstruction: a case report. Transplant Proc 2008;40:1763–1767.PubMedGoogle Scholar
  6. Klaus A, Margreiter R, Pernthaler H, Klima G, Offner FA. Diffuse mesenterial sclerosis: a characteristic feature of chronic small-bowel allograft rejection. Virchows Arch 2003;442:48–55.PubMedGoogle Scholar
  7. Morotti RA, Kaufman SS, Fishbein TM, et al. Calicivirus infection in pediatric small intestine transplant recipients: pathological considerations. Hum Pathol 2004;35:1236–1240.PubMedGoogle Scholar
  8. Parizhskaya M, Redondo C, Demetris A, et al. Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphologic progression. Pediatr Dev Pathol 2003;6:240–250.PubMedGoogle Scholar
  9. Pascher A, Kohler S, Neuhaus P, Pratschke J. Present status and future perspectives of intestinal transplantation. Transpl Int 2008;21:401–414.PubMedGoogle Scholar
  10. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ. A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003;75:1241–1248.PubMedGoogle Scholar
  11. Wu T, Bond G, Martin D, Nalesnik MA, Demetris AJ, Abu-Elmagd K. Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab. Am J Gastroenterol 2006;101:1617–1624.PubMedGoogle Scholar


  1. Banerjee S, Dick AD. Recent developments in the pharmacological treatment and prevention of corneal graft rejection. Expert Opin Investig Drugs 2003;12:29–37.PubMedGoogle Scholar
  2. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008;8:1396–1400.PubMedGoogle Scholar
  3. Hoerbelt R, Madsen JC. Feasibility of xeno-transplantation. Surg Clin North Am2004;84:289–307.PubMedGoogle Scholar
  4. Kanitakis J, McGregor B, Badet L, et al. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation 2007;84:265–267.PubMedGoogle Scholar
  5. Klebe S, Coster DJ , Williams KA. Rejection and acceptance of corneal allografts. Curr Opin Organ Transplant 2009;14:4–9.PubMedGoogle Scholar
  6. Lees VC, McCabe SJ. The rationale for hand transplantation. Transplantation 2002;74:749–753.PubMedGoogle Scholar
  7. Lineaweaver WC. Face transplants and the era of reconstructive transplantation. Ann Plast Surg 2009;62:225.PubMedGoogle Scholar
  8. Morris PJ, Bradley JA, Doyal L, et al. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation 2004;77:330–338.PubMedGoogle Scholar
  9. Schneider MK, Seebach JD. Xenotransplantation literature update: November-December, 2008. Xenotransplantation 2009;16:50–53.PubMedGoogle Scholar
  10. Williams KA, Coster DJ. The immunobiology of corneal transplantation. Transplantation 2007;84:806–813.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Oscar W. Cummings
    • 1
  1. 1.Department of Pathology and Laboratory MedicineIndiana University School of MedicineIndianapolisUSA

Personalised recommendations